Ambrx Biopharma, Inc.
AMAMDelisted Mar 7, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001990550
Ambrx Biopharma, Inc. was delisted on Mar 7, 2024; its insiders filed their last Form 4 on Mar 7, 2024; 68 institutions reported holding it in 13F filings for Q4 2023, worth $912.7M in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding Ambrx Biopharma, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 68 | 0 | −68 |
| Shares | 64.1M | 0 | −64.1M (−100.0%) |
| Value | $912.7M | $0 | −$912.7M (−100.0%) |
New holders (0)
Institutions that held Ambrx Biopharma, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
None.
Sold out (68)
Institutions that held Ambrx Biopharma, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.